INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Hybrid Ophthalmic Trials: Splitting Visits Across Home, Hub, And Site
Hybrid ophthalmic trials combine in-person and remote visits, boosting patient convenience, reducing site burden, and accelerating timelines while maintaining data quality and compliance.
-
The Scout Portal Helps Sites Hit SCRS'25 In 25 Goal
Reducing site training time starts with intuitive tools. Aligning with SCRS’s 25 in 25 goal means eliminating complexity and empowering staff to focus on trial execution.
-
Site Perspectives On BYOD ePRO Use
This study examines participant convenience and compliance, aiming to understand and address the challenges faced by site personnel in global trials.
-
Vendor Selection Bias: Why Structured Decisions Often Fail
Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
-
Uncovering The Root Cause Of Clinical Trial Troubles12/10/2024
Discover essential strategies to prevent clinical trials from reaching a crisis while gaining a deeper understanding of the importance of addressing systemic issues early.
-
Global Vaccine Trials Case Study5/22/2024
Explore targeted strategies for tackling the complexities of international payments and providing comprehensive participant support in global vaccine trials.
-
Should Sponsors Provide Source Document Templates?12/9/2025
Here, we debate sponsor-provided source document templates, weighing regulatory guidance, compliance risks, and operational impacts for smarter clinical trial documentation decisions.
-
Taming The Complex Clinical-Trial Ecosystem4/9/2025
To navigate the growing number of vendor portals required for clinical trials, sites are seeking a vendor- and sponsor-agnostic solution to enable single sign-on and study organization.
-
Navigating The 7 Biggest Challenges In Rare Disease Clinical Trials4/11/2025
Discover how partnering with specialized rare disease CROs allows drug sponsors to accelerate treatment development, navigate trial complexities, and ultimately improve patient outcomes.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Veristat empowers rare disease therapy with science-driven strategies and trusted expertise, supporting over 350 rare disease projects and preparing 40+ marketing applications in the past five years.
-
With three clinical pharmacology units, access to 145,000+ hepatic/renal patients, and 100+ completed studies, we’re your partner for NDA-enabling trials.
-
Customize a platform for on-demand resources and content that keeps your team on the same page, regardless of when they join the study cycle.
-
Partner with Signant Health to enhance trial performance. Our comprehensive eClinical suite and expertise, combined with your CRO’s capabilities, ensure standout proposals and successful studies.
-
CSSi is a global, full-service company offering customized services to support recruitment and retention programs around the world.